Clinical trial
Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
NCT03566407 is registered in ClinicalTrials.gov with Prometheus Laboratories as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Blood and Stool Molecular Biomarkers Longitudinal Detection Study in Crohn's Disease (CD) Patients
- Lead sponsor
- Prometheus Laboratories
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- May 4, 2018
- Completion date
- March 29, 2019
- Enrollment
- 41 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
crohn's disease